Article
Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical Cancer
25 Jan 2012
Abstract excerpt
Standard treatment of locally advanced cervical cancer currently consists of concurrent chemoradiation, leading to a 5-year disease-free survival of 66-79%, indicating that there is still ample room for improvement. Characteristic of cervical cancer is the presence of high risk (HR) human papillomavirus (HPV) DNA in more than 99% of these tumors. When the HR HPV genome integrates into the host genome, oncogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
